FOXA
59
-4
UNP
59
11
F
59
17
DFS
77
17
ORCL
65
7
SRE
69
17
NTAP
59
5
AMG
36
7
MDLZ
30
-8
VLO
40
7
PG
37
-4
MHK
52
7
EQIX
57
-3
PM
50
-16
AN
55
8
OMC
64
2
USB
54
8
CMG
60
3
CAT
69
10
DHI
41
-7
FOXA
59
-4
UNP
59
11
F
59
17
DFS
77
17
ORCL
65
7
SRE
69
17
NTAP
59
5
AMG
36
7
MDLZ
30
-8
VLO
40
7
PG
37
-4
MHK
52
7
EQIX
57
-3
PM
50
-16
AN
55
8
OMC
64
2
USB
54
8
CMG
60
3
CAT
69
10
DHI
41
-7
Financhill
Back

Range Cancer Therapeutics ETF Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Buy
63

CNCR
Range Cancer Therapeutics ETF

Last Price:
15.58
Seasonality Move:
8.86%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Range Cancer Therapeutics ETF Price Quote

$15.58
-0.01 (2.77%)
(Updated: November 7, 2024 at 5:09 AM ET)

Range Cancer Therapeutics ETF Key Stats

Buy
63
Range Cancer Therapeutics ETF (CNCR) is a Buy
Day range:
$15.46 - $15.73
52-week range:
$9.52 - $17.96
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
3.1K
Avg. volume:
3.2K
1-year change:
49.4%
Market cap:
$0
Revenue:
$0
EPS:
$0

How Much Does Range Cancer Therapeutics ETF Make?

Data Unavailable

Is Range Cancer Therapeutics ETF Growing As A Company?

Data Unavailable

Range Cancer Therapeutics ETF Stock Price Performance

What Is Range Cancer Therapeutics ETF 52-Week High & Low?

Range Cancer Therapeutics ETF Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Range Cancer Therapeutics ETF?

Data Unavailable

Is Range Cancer Therapeutics ETF Cash Flow Positive?

Data Unavailable

Range Cancer Therapeutics ETF Return On Invested Capital

Data Unavailable

Range Cancer Therapeutics ETF Earnings Date & Stock Price

Range Cancer Therapeutics ETF Competitors

  • Who Are Range Cancer Therapeutics ETF's Competitors?
    Below is a list of companies who compete with Range Cancer Therapeutics ETF or are related in some way:
    • Virtus LifeSci Biotech Clinical Trls ETF (BBC)
    • Virtus LifeSci Biotech Products ETF (BBP)
    • First Trust Nasdaq Pharmaceuticals ETF (FTXH)
    • Invesco Nasdaq Biotechnology ETF (IBBQ)
    • SPDR® S&P Health Care Services ETF (XHS)

Range Cancer Therapeutics ETF Dividend Yield

Range Cancer Therapeutics ETF Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable